Immune cells in allergic conjunctivitis and allergy shots
Part of Eyes & vision, Immune system & allergy clinical trials.
This study looks at how immune cells work in people with allergic conjunctivitis and whether allergy shots (desensitization therapy) can help. It aims to understand the balance of certain immune cells in your eyes and blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 30 years old.
- You have been diagnosed with allergic conjunctivitis and have active symptoms like itching or redness.
- You have had a positive skin allergy test.
- You have not had any infection in the last 2 months.
- You do not have other active allergic diseases (like asthma or dermatitis), chronic conditions, or autoimmune diseases.
- You have not used steroid eye drops in the last 2 months and are not taking immune-suppressing medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for adults and children aged 5 and older who have allergies to cats (Part A) and/or birch pollen (Part B). The goal is to better understand these allergies. If you are allergic to cats, you must not currently live with a cat and must not have lived with one in the past year.
This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
This trial studies whether vitamin D affects the surface of the eye, the eye’s normal germs, eye inflammation, and vision in children with allergic conjunctivitis. If vitamin D helps, it could improve symptoms and eye comfort.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
This study follows people with suspected or known inherited immune/allergy problems by collecting health information and blood. It may help researchers understand how immune systems and allergies behave over time and support future studies.
Hear when a new Conjunctivitis, Allergic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.